Quantum Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.91M Buy
1,589
+36
+2% +$36.8K 0.19% 56
2026
Q1
$1.43M Sell
1,553
-165
-10% -$167K 0.16% 58
2025
Q4
$1.85M Buy
1,718
+229
+15% +$219K 0.21% 56
2025
Q3
$1.14M Hold
1,489
0.14% 68
2025
Q2
$1.16M Buy
1,489
+381
+34% +$296K 0.16% 65
2025
Q1
$915K Hold
1,108
0.14% 72
2024
Q4
$855K Sell
1,108
-40
-3% -$33.1K 0.13% 67
2024
Q3
$1.02M Sell
1,148
-13
-1% -$11.7K 0.16% 64
2024
Q2
$1.05M Buy
1,161
+35
+3% +$28K 0.18% 60
2024
Q1
$876K Buy
1,126
+18
+2% +$12.8K 0.16% 66
2023
Q4
$646K Hold
1,108
0.16% 42
2023
Q3
$595K Hold
1,108
0.17% 45
2023
Q2
$520K Hold
1,108
0.15% 43
2023
Q1
$380K Hold
1,108
0.12% 53
2022
Q4
$405K Hold
1,108
0.18% 41
2022
Q3
$358K Hold
1,108
0.16% 40
2022
Q2
$337K Buy
+1,108
New +$333K 0.13% 51

Other funds holding LLY

Quantum Financial Advisors's LLY Position: Q2 2026 in Review

Quantum Financial Advisors increased its Eli Lilly (LLY) stake by 2.3% in Q2 2026, buying an estimated $36.8K and bringing the position to 1,589 shares worth $1.91M. The position accounts for 0.19% of the portfolio, ranked #56.

Quantum Financial Advisors first reported a position in LLY in Q2 2022 and has held it in 17 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Quantum Financial Advisors held 1,589 shares of Eli Lilly worth $1.91M as of Q2 2026.
  • Quantum Financial Advisors bought 36 Eli Lilly shares in Q2 2026, an estimated $36.8K.
  • Eli Lilly made up 0.19% of Quantum Financial Advisors's portfolio in Q2 2026, its #56 holding.
  • Quantum Financial Advisors first reported a position in Eli Lilly in Q2 2022 and has held it in 17 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Quantum Financial Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.